KCAS-blog-thumb_2025_ADC March 3 - March 6

KCAS Bio is delighted to announce our participation in the 15th Annual World ADC, taking place in London, United Kingdom, from March 3-6, 2025. This premier event brings together the brightest minds in the field of antibody-drug conjugates (ADCs) to explore the latest scientific advancements, strategies, and technologies shaping the…

KCAS-blog-thumb_2025_EIP February 24 - February 26

KCAS Bio is excited to announce our attendance at the 16th Open Scientific EIP (European Immunogenicity Platform) Symposium, taking place in Lisbon, Portugal, from February 24-26, 2025. This premier event brings together global leaders in immunogenicity to share insights, exchange ideas, and drive innovation in the development of biologics and…

KCAS-blog-thumb_2025_ECCO February 19 - February 22

KCAS Bio is proud to announce our participation in the 20th Congress of ECCO (European Crohn’s and Colitis Organisation), taking place in Berlin, Germany, from February 19-22, 2025. This prestigious event brings together global experts, researchers, and clinicians dedicated to improving the understanding and treatment of inflammatory bowel diseases (IBD).

KCAS-event-thumb_2024-011_SOT March 16 - March 20

KCAS Bio is excited to announce our participation in the Society of Toxicology (SOT) Annual Meeting and ToxExpo, taking place in Orlando, Florida on March 16th-20th. As one of the largest gatherings of toxicologists and life sciences professionals, this event offers a unique platform to connect with leaders in toxicology…

KCAS-blog-thumb_2024-12_The Top 4 Challenge2 Blogs
Read article The Top 4 Challenges during Biomarker Assay Development: from Qualification to Validation

Biomarker assay development is pivotal to clinical research and the success of a study, yet the journey from qualification to validation is often complex. In this blog, we discuss four must-know essentials to optimize your assay development process. 1. Understand the Context of Use: Qualification vs. Validation The FDA emphasizes…

KCAS-Blog_Thumbnail-Banner_dose-form Blogs
Read article Dose Formulation Analysis: Accurate and On-Time

Dose Formulation Analysis is an essential step in regulated nonclinical studies. Robust analytical methods, rapid turnaround, and efficient communication helps ensure the dose form results for your GLP studies are delivered on time. At KCAS Bio, our scientific expertise allows us to develop methods that achieve…

KCAS-podcast-thumb_TWB-084 Podcasts
Listen to podcast Podcast (The Weekly Bioanalysis) Eps #84: “Small Molecule LC-MS Development and Evolving Approaches to ADC Payloads”

In episode 84 of “The Weekly Bioanalysis”, our special guest, Bryan Parmentier, joins Dom and John to discuss his background and current role at KCAS Bio, offering insights into the field of small molecule method development. He delves into the typical challenges encountered when working with LC-MS analytes, and how…

KCAS-blog-thumb_2024-12_GeneralGlobalPerspective Blogs
Read article Global Perspectives on the Bioanalytical Market: Insights from 2024 and Beyond

As the bioanalytical market evolves at a rapid pace, KCAS Bio stands at the forefront, offering an innovative approach to challenges and opportunities alike. Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with…

KCAS-podcast-thumb_TCF-015 Podcasts
Listen to podcast Podcast (The Conversational Flow) Eps #15: “Fantastic Fluorophores and Where to Find Them (w/ Kelly Lundsten)”

In this exciting 15th episode of The Conversational Flow podcast, titled “Fantastic Fluorophores and Where to Find Them,” hosts Brian Wile and Adam Cotty from KCAS Bio are joined by special guest Kelly Lundsten from FluoroFinder. Together, they dive into the fascinating world of spectral flow cytometry, exploring key questions such as…

KCAS-blog-thumb_2024-Brian Blogs
Read article Global Perspectives on the 2024 Bioanalytical Market: An Interview with Brian Wile

Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with our CEO, John Bucksath, and key team members Amy Mize, Mouhssin Oufir, and Brian Wile, KCAS Bio delivers a roadmap…

KCAS-blog-thumb_2024-AmyMize Blogs
Read article Global Perspectives on the 2024 Bioanalytical Market: An Interview with Amy Mize

Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with our CEO, John Bucksath, and key team members Amy Mize, Mouhssin Oufir, and Brian Wile, KCAS Bio delivers a roadmap…

KCAS-blog-thumb_2024-Mouhssin Blogs
Read article Global Perspectives on the 2024 Bioanalytical Market: An Interview with Mouhssin Oufir

Drawing on the insights of our leadership team, we’ve compiled a global perspective on the state of the bioanalytical industry in 2024. Through thoughtful discussions with our CEO, John Bucksath, and key team members Amy Mize, Mouhssin Oufir, and Brian Wile, KCAS Bio delivers a roadmap…